The estimated Net Worth of Michael Kalkstein is at least $5.39 Million dollars as of 1 April 2020. Michael Kalkstein owns over 913 units of Cooper Companies stock worth over $99,070 and over the last 21 years Michael sold COO stock worth over $5,287,244.
Michael has made over 20 trades of the Cooper Companies stock since 2003, according to the Form 4 filled with the SEC. Most recently Michael exercised 913 units of COO stock worth $99,070 on 1 April 2020.
The largest trade Michael's ever made was exercising 35,000 units of Cooper Companies stock on 10 September 2012 worth over $1,154,300. On average, Michael trades about 2,620 units every 90 days since 2003. As of 1 April 2020 Michael still owns at least 913 units of Cooper Companies stock.
You can see the complete history of Michael Kalkstein stock trades at the bottom of the page.
Michael's mailing address filed with the SEC is C/O THE COOPER COMPANIES, INC., 6101 BOLLINGER CANYON ROAD, SUITE 500, SAN RAMON, CA, 94583.
Over the last 21 years, insiders at Cooper Companies have traded over $45,273,696 worth of Cooper Companies stock and bought 5,157 units worth $1,262,486 . The most active insiders traders include Robert S Weiss, William A Kozy und Lawrence Erik Kurzius. On average, Cooper Companies executives and independent directors trade stock every 18 days with the average trade being worth of $1,325,775. The most recent stock trade was executed by Brian G Andrews on 5 September 2024, trading 24,788 units of COO stock currently worth $939,713.
company overview the cooper companies, inc. ("cooper") is a global medical device company publicly traded on the nyse euronext (nyse:coo). cooper is dedicated to being a quality of life company™ with a focus on delivering shareholder value. cooper operates through two business units, coopervision and coopersurgical. coopervision brings a refreshing perspective on vision care with a commitment to crafting a wide range of high-quality products for contact lens wearers and providing focused practitioner support. coopersurgical focuses on supplying women's health clinicians with market leading products and treatment options to improve the delivery of healthcare to women. headquartered in pleasanton, ca, cooper has approximately 9,000 employees with products sold in over 100 countries. for more information, please visit www.coopercos.com.
Cooper Companies executives and other stock owners filed with the SEC include: